ORBIMED ADVISORS LLC – CytomX Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-20.77%
quarter
CytomX Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -2.12M shares | -3.88M | $1.45 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -1.78M | $1.83 | 2.12M | |
| Q1 2022 | share | Decrease | -33.89% | -1.08M shares | -8.24M | $2.67 | 2.12M |
| Q4 2021 | share | Increase | +76.44% | 1.39M shares | 4.64M | $4.4 | 3.21M |
| Q3 2021 | share | Increase | +20.40% | 308.7K shares | -305K | $5.09 | 1.82M |
| Q2 2021 | share | Increase | 0.00% | 1.51M shares | 9.57M | $6.33 | 1.51M |